Testing effectiveness (Phase 2)Ended earlyNCT03637803
What this trial is testing
Live Biotherapeutic Product MRx0518 and Pembrolizumab Combination Study in Solid Tumors
Who this might be right for
OncologySolid TumorNon Small Cell Lung Cancer+3 more
4D pharma plc 63